Natixis’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,334
| Closed | -$17.6K | – | 962 |
|
|
2024
Q4 | $17.6K | Hold |
2,334
| – | – | ﹤0.01% | 925 |
|
|
2024
Q3 | $17.7K | Hold |
2,334
| – | – | ﹤0.01% | 820 |
|
|
2024
Q2 | $14.4K | Sell |
2,334
-9,350
| -80% | -$57.8K | ﹤0.01% | 816 |
|
|
2024
Q1 | $59.4K | Buy |
11,684
+9,350
| +401% | +$47.5K | ﹤0.01% | 797 |
|
|
2023
Q4 | $14K | Hold |
2,334
| – | – | ﹤0.01% | 872 |
|
|
2023
Q3 | $16.5K | Hold |
2,334
| – | – | ﹤0.01% | 864 |
|
|
2023
Q2 | $16.4K | Sell |
2,334
-593
| -20% | -$4.18K | ﹤0.01% | 896 |
|
|
2023
Q1 | $24.4K | Sell |
2,927
-1,907
| -39% | -$15.9K | ﹤0.01% | 848 |
|
|
2022
Q4 | $55.5K | Buy |
+4,834
| New | +$55.5K | ﹤0.01% | 856 |
|